124 related articles for article (PubMed ID: 38654633)
21. Diastereoselective Synthesis and Two-Step Photocleavage of Ruthenium Polypyridyl Complexes Bearing a Bis(thioether) Ligand.
Meijer MS; Bonnet S
Inorg Chem; 2019 Sep; 58(17):11689-11698. PubMed ID: 31433170
[TBL] [Abstract][Full Text] [Related]
22. A theoretical investigation into the photophysical properties of ruthenium polypyridine-type complexes.
Charlot MF; Pellegrin Y; Quaranta A; Leibl W; Aukauloo A
Chemistry; 2006 Jan; 12(3):796-812. PubMed ID: 16267865
[TBL] [Abstract][Full Text] [Related]
23. A Highly Efficient Red-Emitting Ruthenium Complex with 3,5-Difluorophenyl Substituents.
Zhu Y; Fei T; Ma Y
Chempluschem; 2016 Jan; 81(1):73-79. PubMed ID: 31968735
[TBL] [Abstract][Full Text] [Related]
24. RGD labeled Ru(II) polypyridyl conjugates for platelet integrin αIIbβ3 recognition and as reporters of integrin conformation.
Adamson K; Dolan C; Moran N; Forster RJ; Keyes TE
Bioconjug Chem; 2014 May; 25(5):928-44. PubMed ID: 24720819
[TBL] [Abstract][Full Text] [Related]
25. Photophysical properties of ruthenium(II) polypyridyl DNA intercalators: effects of the molecular surroundings investigated by theory.
Véry T; Ambrosek D; Otsuka M; Gourlaouen C; Assfeld X; Monari A; Daniel C
Chemistry; 2014 Sep; 20(40):12901-9. PubMed ID: 25145959
[TBL] [Abstract][Full Text] [Related]
26. Visible Light-Activated CO Release and
Pickens RN; Neyhouse BJ; Reed DT; Ashton ST; White JK
Inorg Chem; 2018 Sep; 57(18):11616-11625. PubMed ID: 30160480
[TBL] [Abstract][Full Text] [Related]
27. Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release.
Hufziger KT; Thowfeik FS; Charboneau DJ; Nieto I; Dougherty WG; Kassel WS; Dudley TJ; Merino EJ; Papish ET; Paul JJ
J Inorg Biochem; 2014 Jan; 130():103-11. PubMed ID: 24184694
[TBL] [Abstract][Full Text] [Related]
28. Effect of Alkyl Chain Length on the Photophysical, Photochemical, and Photobiological Properties of Ruthenium(II) Polypyridyl Complexes for Their Application as DNA-Targeting, Cellular-Imaging, and Light-Activated Therapeutic Agents.
Estalayo-Adrián S; Blasco S; Bright SA; McManus GJ; Orellana G; Williams DC; Kelly JM; Gunnlaugsson T
ACS Appl Bio Mater; 2021 Sep; 4(9):6664-6681. PubMed ID: 35006970
[TBL] [Abstract][Full Text] [Related]
29. A theoretical study of ruthenium complexes with 2,2'-biimidazole-like ligands: structural, optical and emissive properties.
Xia SH; Fang WH; Cui G; Daniel C
Photochem Photobiol Sci; 2016 Aug; 15(9):1138-1147. PubMed ID: 27454575
[TBL] [Abstract][Full Text] [Related]
30. Ruthenium-Based Photoactivated Chemotherapy.
Bonnet S
J Am Chem Soc; 2023 Nov; 145(43):23397-23415. PubMed ID: 37846939
[TBL] [Abstract][Full Text] [Related]
31. Yellow-light sensitization of a ligand photosubstitution reaction in a ruthenium polypyridyl complex covalently bound to a rhodamine dye.
Bahreman A; Cuello-Garibo JA; Bonnet S
Dalton Trans; 2014 Mar; 43(11):4494-505. PubMed ID: 24395135
[TBL] [Abstract][Full Text] [Related]
32. Ruthenium nitrosyl complexes with 1,4,7-trithiacyclononane and 2,2'-bipyridine (bpy) or 2-phenylazopyridine (pap) coligands. Electronic structure and reactivity aspects.
De P; Maji S; Chowdhury AD; Mobin SM; Mondal TK; Paretzki A; Lahiri GK
Dalton Trans; 2011 Dec; 40(46):12527-39. PubMed ID: 21986798
[TBL] [Abstract][Full Text] [Related]
33. A photoactivatable chemotherapeutic Ru(II) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway.
Elias MG; Mehanna S; Elias E; Khnayzer RS; Daher CF
Chem Biol Interact; 2021 Oct; 348():109644. PubMed ID: 34508709
[TBL] [Abstract][Full Text] [Related]
34. Theoretical study on photooxidation mechanism of ruthenium complex [Ru(II)-(bpy)2 (TMBiimH2 )](2+) with molecular oxygen.
Liu LH; Wu D; Xia SH; Cui G
J Comput Chem; 2016 Sep; 37(24):2212-9. PubMed ID: 27384925
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and properties of metal-to-ligand charge-transfer excited states in 2,3-bis(2-pyridyl)pyrazine and 2,2'-bypyridine ruthenium complexes. Perturbation-theory-based correlations of optical absorption and emission parameters with electrochemistry and thermal kinetics and related Ab initio calculations.
Seneviratne DS; Uddin J; Swayambunathan V; Schlegel HB; Endicott JF
Inorg Chem; 2002 Mar; 41(6):1502-17. PubMed ID: 11896719
[TBL] [Abstract][Full Text] [Related]
36. A Synthetic Route to a Ruthenium Complex via Successive Photosubstitution Reactions.
Hirahara M; Umemura Y
Inorg Chem; 2021 Sep; 60(17):13193-13199. PubMed ID: 34492768
[TBL] [Abstract][Full Text] [Related]
37. NIR-Light-Driven Generation of Reactive Oxygen Species Using Ru(II)-Decorated Lipid-Encapsulated Upconverting Nanoparticles.
Meijer MS; Talens VS; Hilbers MF; Kieltyka RE; Brouwer AM; Natile MM; Bonnet S
Langmuir; 2019 Sep; 35(37):12079-12090. PubMed ID: 31389710
[TBL] [Abstract][Full Text] [Related]
38. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
39. Photophysical properties of ruthenium(II) polypyridyl-gold(I) ethynyl dyads and triads containing mono- or diethynylphenanthroline incorporated into gold(I) triphenylphosphine organometallics.
Shiotsuka M; Tsuji Y; Keyaki K; Nozaki K
Inorg Chem; 2010 May; 49(9):4186-93. PubMed ID: 20364844
[TBL] [Abstract][Full Text] [Related]
40. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
